Month: February 2015

Doctors downplay the benefits of breast milk for adults and warn of possibly contaminated milk sold over the Internet.
Go to Source

(Reuters) – British drugmaker Celsus Therapeutics Plc’s stock plunged as much as 83 percent after the company’s skin cream failed the main goal of a mid-stage study. Celsus chief executive Gur Roshwalb said he was “surprised” by the number of patients who responded to a placebo. The cream, MRX-6, is being developed to treat atopic dermatitis, or eczema, a chronic skin rash or inflammation that often appears in infancy or childhood. The National Institutes of Health (NIH) estimates that eczema affects between 9 and 30 percent of the U.S. population.
Go to Source

Recently I spent a few weeks in California, partly for work but mostly intended for rest and relaxation and to celebrate my brother's 50th birthday. Throughout life, one of my absolutely most favorite activities has been meeting new people. To me, the world is a massive library and each person is a charming book waiting to be encountered,…

Go to Source

By Kathryn Doyle (Reuters Health) – Fifty percent of women will experience hot flashes and night sweats characteristic of menopause for about seven years, according to a new study. The duration of symptoms, which are estimated for the first time in the new study, varies depending on a woman’s race and when her symptoms started, write the researchers in JAMA Internal Medicine. “We were a little surprised at the extent, but it’s important to recognize that there is huge variation,” said lead author Dr. Nancy Avis of Wake Forest Baptist Medical Center in Winston-Salem, North Carolina. One in five women in the new study did not report experiencing any of the so-called vasomotor symptoms, like hot flashes or night sweats, during menopause.
Go to Source

(Reuters) – Pharmacyclics Inc said its cancer drug developed with a Johnson & Johnson unit improved overall response rate in high-risk leukemia patients. Those administered with Imbruvica showed an overall response rate of 88 percent, while 76.6 percent survived without the disease getting worse at 24 months. All 16 patients enrolled in the small study suffered from high-risk chronic lymphocytic leukemia (CLL) and had failed to benefit from stem cell transplants and other therapies. Patients who relapse of CLL following stem cell transplant are hard to treat with chemotherapy as they do not produce enough blood cells or develop post-transplant complications.
Go to Source

This is called a “permissive” dietary plan, which focuses on what you can eat … This positive approach to weight loss may produce more beneficial effects than a … “We chose dietary fiber because it exerts clinical benefits on several …
Go to Source